BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
38 hedge funds and large institutions have $40.8M invested in BioSpecifics Technologies Corp. in 2013 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 7 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 12
3% more capital invested
Capital invested by funds: $39.8M → $40.8M (+$1.03M)
7% less funds holding
Funds holding: 41 → 38 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
+$837K |
| 2 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
+$467K |
| 3 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$444K |
| 4 |
Bank of New York Mellon
New York
|
+$302K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$283K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$1.86M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$1.27M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$831K |
| 4 |
AC
Amici Capital
New York
|
-$487K |
| 5 |
Goldman Sachs
New York
|
-$330K |
BSTC Hedge Fund Activity: Q4 2013 in Review
38 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q4 2013, worth a combined $40.8M — up 2.6% from $39.8M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of BSTC and 4 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 16 added.
The largest buyer was Northpointe Capital, adding an estimated $837K. The largest seller was BlackRock Advisors, cutting an estimated $1.86M.
- 38 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q4 2013, down from 41 in Q3 2013.
- Funds reported $40.8M of BioSpecifics Technologies Corp. stock for Q4 2013, up 2.6% quarter-over-quarter.
- 4 funds opened new BioSpecifics Technologies Corp. positions in Q4 2013 and 7 closed out, a net change of -3 holders.
- The largest BioSpecifics Technologies Corp. buyer in Q4 2013 was Northpointe Capital, an estimated $837K added.
- The largest BioSpecifics Technologies Corp. seller in Q4 2013 was BlackRock Advisors, an estimated $1.86M sold.
Based on aggregated 13F filings for Q4 2013.